Optimizing Outcomes in The Management of Multidrug-Resistant Gram-Negative Bacterial Infections

Release Date: 28 January, 2026
Expiration Date: 28 January, 2027

Activity Overview
This activity equips clinicians to diagnose and manage MDR gram-negative infections using real-world cases, rapid diagnostics, and evidence-based antimicrobial selection across acute care settings.

Target Audience
Infectious disease specialists, critical care specialists, nurse practitioners, hospital pharmacists, and clinical microbiologists.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Orakle LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Faculty members
Erin K. McCreary PharmD, BCIDP, FIDSA
Julian de la Torre-Cisneros MD, PhD
Matteo Bassetti MD, PhD (faculty)
Case simulations
A 64-year-old woman on long-term immunosuppressive therapy presents to the emergency department with fever and chills.
A 56-year-old patient develops a fever during hospitalization.
A 68-year-old man presents with dysuria, urgency, and frequency.
A 62-year-old woman presents with fever and diffuse abdominal pain after sigmoid colectomy for diverticulitis.
Start case
Start case
Start case
Start case
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Criteria for Success
- To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at ketrea@akhcme.com.https://akhcme.com/content/optimizing-outcomes-management-multidrug-resistant-gram-negative-bacterial-infections

Credit Claim Instructions
1. Click the claim link
2. Login or Create an account in the system. (All 1 st time users required to create an account)
Once complete, the course will appear in your 'Pending Activities' list, found under the 'Activities' tab on your profile page (upper right-hand corner).
3. Proceed to Register/Take Course Tab to complete the Course Evaluation & Certificate steps for the activity.
4. Click get started

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
‍
Commercial Support
This activity is supported by an independent medical education grant from Pfizer.

Disclosures
Matteo Bassetti MD, PhD (faculty)
 Nothing to disclose
‍
Erin K. McCreary PharmD, BCIDP, FIDSA (faculty)
Advisor, Speaker: GSK

Julian de la Torre-Cisneros MD, PhD (faculty)
Researcher: MSD, Advanz, Qiagen, Takeda
Speaker: MSD, Shionogi, Pfizer, Menarini, Advanz, Qiagen, Takeda

Dorothy Caputo, MA, BSN, RN - President
Nothing to disclose
‍
Michele Bielarski, RN (planner/reviewer)
Nothing to disclose
‍
AKH Inc Staff and Planners
Nothing to disclose
‍
Orakle LLC Staff and Planners
Nothing to disclose

‍Disclosures
‍It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

‍Disclosure of Unlabeled Use and Investigational Product 
‍This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

‍Disclaimer 
‍This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.